Organogenesis Holdings (ORGO) Deferred Taxes (2023 - 2026)
Organogenesis Holdings (ORGO) posted quarterly Deferred Taxes of -$15.4 million for Q1 2026, down 1114.14% year-over-year from $1.5 million in Q1 2025, and down 214.25% quarter-over-quarter from $13.5 million in Q4 2025.
Organogenesis Holdings (ORGO) Deferred Taxes (2023 - 2026) Analysis & Trends
Organogenesis Holdings' Deferred Taxes history runs 4 years deep, the most recent figure standing at -$15.4 million for Q1 2026.
- In Q1 2026, Deferred Taxes fell 1114.14% year-over-year to -$15.4 million; the TTM figure through Mar 2026 stood at -$6.8 million (down 80.46% YoY), while the FY2025 annual figure was $7.3 million, up 189.41% from the prior year.
- Deferred Taxes for Q1 2026 stood at -$15.4 million, down from $13.5 million in the prior quarter.
- The five-year high for Deferred Taxes was $13.5 million in Q4 2025, with the low at -$15.4 million in Q1 2026.
- The 4-year median for Deferred Taxes is -$1.1 million (2025), against an average of -$1.3 million.
- The sharpest annual moves came in 2024 and 2025: Deferred Taxes plunged 2453.85% in 2024, then soared 4496.73% in 2025.
- Organogenesis Holdings' Deferred Taxes stood at $13000.0 in 2023, then slumped by 2453.85% to -$306000.0 in 2024, then jumped by 4496.73% to $13.5 million in 2025, then slumped by 214.25% to -$15.4 million in 2026.
- Business Quant data shows ORGO's Deferred Taxes at -$15.4 million in Q1 2026, $13.5 million in Q4 2025, and -$3.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 25.00 Mn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | -33.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 25.70 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -124.50 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | -25.30 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Organogenesis Holdings | 238.69 Mn | 191.85 Mn | 20.08 Mn | 45.33 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 45.33 Mn |
| Mar 31, 2026 | -15.37 Mn |
| Dec 31, 2025 | 13.45 Mn |
| Sep 30, 2025 | -3.84 Mn |
| Jun 30, 2025 | -1.03 Mn |
| Mar 31, 2025 | -1.27 Mn |
| Dec 31, 2024 | -306,000.00 |
| Sep 30, 2024 | -2.20 Mn |
| Dec 31, 2023 | 13,000.00 |